NIH invites applications to develop or adapt advanced technologies to detect perturbation-induced cellular signatures.
This initiative is funded through the NIH Common Fund, which supports cross-cutting programs that are expected to have exceptionally high impact. All Common Fund initiatives encourage investigators to develop bold, innovative, and often risky approaches to address problems that may seem intractable or to seize new opportunities that offer the potential for rapid progress.
Cancer biology has benefitted from the systematic and large-scale study of cellular signatures of disease. The time is right to expand the scope of such research beyond cancer and to develop innovative tools to advance it. Knowledge of perturbation-induced cellular signatures could provide significant insight to fundamental issues in biology by addressing, for example, differentiation of signatures among cell states across the lifespan or across levels of cellular complexity and specialization.
Letters of Intent Due January 22, 2011
Applications Due February 22, 2011
Potential applicants should contact Dr. Jennifer Couch, chief, Structural Biology and Molecular Applications Branch, Division of Cancer Biology, NCI, at 301-435-5226 or email@example.com. For more information visit http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-10-004.html.